TrialBMC cancer2012

Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.

Janne B Kjersem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.